Review of Savaria Corporation

SEP 05, 2024 - Savaria Corporation (SIS) is a global leader in the accessibility industry, providing solutions for the seniors and individuals with disabilities. IS has one of the industry’s most comprehensive product lines aimed at improving the comfort, mobility, and independence of its target market. As the company continues to implement initiatives under Savaria One we think the growth story is easy story for investors to get behind. We are maintaining our rating of a B+ and have a positive mid-term outlook.

Download Report

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

WSP Global Inc. (WSP $288.28)
- $288.28 P/E (TTM): 47.42X Cap: $37.62B
- View WSP Profile
- View Questions on WSP
- View Reports on WSP
Alimentation Couche-Tard Inc. (ATD $73.64)
- $73.64 P/E (TTM): 19.8X Cap: $69.26B
- View ATD Profile
- View Questions on ATD
Savaria Corporation (SIS $20.51)
- $20.51 P/E (TTM): 26.86X Cap: $1.46B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: Good morning 5i
I have held sis for quite awhile, hopeful that its emphasis on the demographic situation would pay off. It does seem to be getting better but as a small cap it doesn’t have the umph that i was hoping for. I have lately been reconsidering my portfolio, anyway and wondering whether i should abandon that hope sell sis and buy something like wsp global or adt, which is down. That way i am leaving behind the risk of a small cap stock, getting possibly more stability in my portfolio and with these two stocks, the possibility of a decent gain. I have a well balanced portfolio, so difference in sector is not a problem
Thanks for your great service for us all

Read Answer Asked by joseph on August 28, 2025

Amgen Inc. (AMGN $276.39)
- $276.39 P/E (TTM): 23.1X Cap: $148.79B
- View AMGN Profile
- View Questions on AMGN
Gilead Sciences Inc. (GILD $114.55)
- $114.55 P/E (TTM): 23.43X Cap: $142.13B
- View GILD Profile
- View Questions on GILD
AbbVie Inc. (ABBV $218.34)
- $218.34 P/E (TTM): 105.37X Cap: $385.71B
- View ABBV Profile
- View Questions on ABBV
Abbott Laboratories (ABT $133.73)
- $133.73 P/E (TTM): 16.64X Cap: $232.75B
- View ABT Profile
- View Questions on ABT
The Cigna Group (CI $302.76)
- $302.76 P/E (TTM): 16.81X Cap: $80.81B
- View CI Profile
- View Questions on CI
Johnson & Johnson (JNJ $178.06)
- $178.06 P/E (TTM): 19.09X Cap: $428.82B
- View JNJ Profile
- View Questions on JNJ
Medtronic plc. (MDT $94.03)
- $94.03 P/E (TTM): 26.11X Cap: $120.61B
- View MDT Profile
- View Questions on MDT
Savaria Corporation (SIS $20.51)
- $20.51 P/E (TTM): 26.86X Cap: $1.46B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: I am mostly content with my health care stocks with the exception of MDT. It has been essentially flat since about 2016 except for the dividend. It did peak around 2022 but has fallen down to previous levels.
What do you think of the longer term for MDT?
Would you make any other changes for slow but reliable growth and higher end of dividends.
As always, thank you for the great service.

Read Answer Asked by Tulio on August 21, 2025

Savaria Corporation (SIS $20.51)
- $20.51 P/E (TTM): 26.86X Cap: $1.46B
- View SIS Profile
- View Questions on SIS
- View Reports on SIS

Q: Could you comment on the Q2, also do you feel the growth rate of Savaria is enough for share holders... is growth enough to drive share price higher?

Read Answer Asked by Harry on August 07, 2025